Also trades as: BDMS-R.BK (SET) · $vol 41M · BDMS.BK (SET) · $vol 40M · BDUUY (OTC) · $vol 0M · BDUUF (OTC) · $vol 0M
BDULF OTC
Bangkok Dusit Medical Services Public Company Limited
1W: -6.5%
1M: +18.4%
3M: +16.1%
YTD: +6.6%
1Y: +3.2%
3Y: +121.4%
$0.65
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
$23.4B
+2.1% ▲
5Y CAGR: +14.9%
Capital Expenditures
$10.4B
+10.9% ▲
5Y CAGR: +9.4%
Free Cash Flow
$13.0B
+15.5% ▲
5Y CAGR: +20.9%
Dividends Paid
$11.9B
-7.1% ▼
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$422M
+0.0% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $10.6B | $16.5B | $18.7B | $20.3B | $15.8B |
| Depreciation & Amort. | $6.3B | $5.9B | $5.8B | $6.1B | $6.8B |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | -$349M | -$138M | -$728M | -$231M | -$952M |
| Other Non-Cash Items | -$2.0B | -$2.0B | -$3.0B | -$3.3B | $1.7B |
| Operating Cash Flow | $14.6B | $20.3B | $20.8B | $23.0B | $23.4B |
| — Investing Activities — | |||||
| Capital Expenditures | -$4.4B | -$5.1B | -$7.7B | -$10.7B | -$11.3B |
| Acquisitions (Net) | $21M | $863K | $0 | $0 | $379M |
| Investment Purchases | -$493M | -$1.1B | -$84M | -$206M | -$230M |
| Investment Sales | $20M | $233M | $719M | $385M | $446M |
| Other Investing | $60M | $52M | -$643M | -$834M | $32 |
| Investing Cash Flow | -$4.8B | -$5.9B | -$7.8B | -$11.4B | -$10.7B |
| — Financing Activities — | |||||
| Net Debt Issuance | -$5.6B | -$2.7B | -$6.9B | -$558M | -$999M |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | -$12.7B | -$7.9B | -$10.3B | -$11.1B | -$11.9B |
| Other Financing | -$187M | -$2.0B | -$687M | -$292M | -$773M |
| Financing Cash Flow | -$18.5B | -$12.6B | -$17.9B | -$12.0B | -$13.7B |
| Net Change in Cash | -$8.7B | $1.7B | -$4.9B | -$422M | -$422M |
| Cash End of Period | $10.9B | $12.7B | $7.8B | $7.4B | $6.3B |
| Free Cash Flow | $10.2B | $15.2B | $12.5B | $11.3B | $13.0B |